IMF TV

From our weekly series “Ask Dr. Durie” to comprehensive news from key cancer medical conferences around the world, IMF-TV is your all-access ticket to critical myeloma research, patient education and guidance. Check back often for regularly updated content. 

Dec
03
IMWG Conference Series: 60th ASH Meeting
Patients, caregivers, and doctors around the world can view the IMF's popular livestream IMWG Conference Series, "Making Sense of Treatment" from the 2018 ASH Meeting at 8:00pm PT/10:00pm CT/11:00pm(...)
Nov
30
New Strategies for Multiple Myeloma Care: Next Steps for the Future
Join us for this year’s International Myeloma Foundation and Clinical Care Options cosponsored symposium, where an esteemed panel of international experts will offer their perspectives on practice-(...)
Nov
15
What is the status of Empliciti® (elotuzumab), the new immunotherapy?
In this week’s video, Dr. Brian G.M. Durie explains the recent FDA approval for the use of elotuzumab, pomalidomide, and dexamethasone (EPd) for the treatment of relapsed or refractory myeloma in(...)
Nov
08
How important is the FDA approval of once-weekly dosage of Kyprolis (carfilzomib) for multiple myeloma patients?
In this week’s video, Dr. Brian G.M. Durie explains the results of the A.R.R.O.W. trial, which proved the efficacy and safety of once-a-week dosing of Kyprolis for myeloma patients.
Nov
01
What are myeloma warriors?
In this week’s video, Dr. Brian G.M. Durie talks about ways myeloma patients, caregivers, or family members can give back to the myeloma community. BOTTOM LINE: ​ The Myeloma Warrior Spirit means(...)
Nov
01
Living Well Teleconference: Clinical Trials in Myeloma
This teleconference will provide an overview of clinical trials and their importance in medicine. Issues addressed will include types of trials (phase 1, 2, 3…), how to interpret results of trials,(...)